Coherus BioSciences Inc (CHRS) — Strategic Asset Allocation Index
Coherus BioSciences Inc (CHRS) has a Strategic Asset Allocation Index of 536.7% as of March 2022. Strategic assets (PP&E of $67.42 Million plus long-term investments of $-) total $67.42 Million, measured against net assets of $12.56 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Coherus BioSciences Inc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Coherus BioSciences Inc Strategic Asset Allocation Index (2012–2021)
This chart shows how Coherus BioSciences Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2012 to 2021. As of March 2022, the index stands at 536.7%, representing strategic assets of $67.42 Million against net assets of $12.56 Million USD. For live market cap and overall valuation, see Coherus BioSciences Inc (CHRS) market capitalisation.
Annual Strategic Asset Allocation Index for Coherus BioSciences Inc (2012–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Coherus BioSciences Inc from 2012 to 2021, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See CHRS book value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 64.9% | $63.42 Million | $63.42 Million | $- | $97.73 Million | ▲ +47.8 pp |
| 2020 | 17.1% | $47.96 Million | $47.96 Million | $- | $280.97 Million | ▲ +1.4 pp |
| 2019 | 15.7% | $16.49 Million | $16.49 Million | $- | $105.21 Million | ▼ -26.2 pp |
| 2017 | 41.8% | $12.77 Million | $12.77 Million | $- | $30.54 Million | ▼ -13.8 pp |
| 2016 | 55.7% | $10.77 Million | $10.77 Million | $- | $19.35 Million | ▲ +49.0 pp |
| 2014 | 6.7% | $4.47 Million | $4.47 Million | $- | $66.76 Million | ▼ -10.8 pp |
| 2012 | 17.5% | $1.60 Million | $1.60 Million | $- | $9.19 Million | — |